Background: The biofilm production is an important phenomenon by bacteria such as Staphylococcus aureus that contribute to the multiple drug resistance. Moreover, biofilm formation by multidrug-resistant Staphylococcus aureus causes evading from immune responses. Objective: The aim of this study was to detect biofilm formation and presence of several related genes among multidrug-resistant (MDR) isolates of Staphylococcus aureus. Methods: This cross sectional study was conducted at a hospital in Tehran, Iran from July 2012 to January 2013. Patients admitted with the infections of the different sites of the body were selected as study population. Staphylococcus aureus isolates were collected from hospitalized patients and identified by conventional diagnostic tests. The multidrug-resistant MRSA isolates were detected by antibiotic susceptibility test. The phenotypic biofilm formation was detected by micro-titre tissue plate assay. The polymerase chain reaction (PCR) was performed to detect the mecA, Staphylococcal Cassette Chromosome mec (SCCmec) types, accessory gene regulatory (agr) genes, the icaADBC and several genes encoding staphylococcal surface proteins including clfAB, fnbAB, fib, eno, can, ebps and bbp genes with specific primers. Results: A total number of 209 Staphylococcus aureus were isolated of which 64(30.6%) isolates were methicillin-resistant; among which 36(56.2%) isolates were MDR. These isolates were resistant to amoxicillin, tetracycline, ciprofloxacin, gentamicin, erythromycin and trimethoprim-sulfamethoxazole. All the isolates were susceptible to vancomycin and linezolid. All the MDR-MRSA harbored SCCmec type III. All the MDR-MRSA isolates were strong biofilm producers in the phenotypic test. Conclusions: Multidrug-resistant MRSA isolates produced biofilm strongly and the majority of these isolates harbored most of biofilm related genes.[Bangladesh J Infect Dis 2014;1(2):27-31]
Introduction
The development of multidrug resistance by Staphylococcus aureus (MDR SA) is a public health concern especially due to MRSA isolates in nosocomial settings. In the hospital milieu, infected and colonized patients contribute to the transmission and spreading of S. aureus and hospital personnel, serving as reservoirs, facilitate further dissemination [1] [2] . Infections caused by MRSA often prove difficult to treat because of high levels of resistance to multiple antibiotics as a result of both intrinsic and acquired mechanisms 3 . Moreover, in recent years vancomycin resistance have made treatment of these isolates very difficult 4 . Drug resistance in S. aureus is occurred by complex genetic arrays such as Staphylococcal cassette chromosome mec (SCCmec) elements for methicillin-resistance and likewise all the beta-lactam antibiotics via production of new Penicillin Binding Protein2a [PBP2a] 5 . MRSA isolates that are acquired from nosocomial milieu are referred as Healthcare Associated (HA)-MRSA. Various nosocomial infections such as those associated with the use of central venous catheters, prosthetic heart valves, urinary catheters and orthopedics devices contribute to the biofilm formation and persistent infections that culminate in evading immune system responses and antibiotic resistance 6 . Susceptibility tests with invitro biofilm models have depicted the survival of bacteria in biofilms after treatment with antibiotics with even much more than the minimum inhibitory concentrations. Moreover, in the body, chemotherapy dose not kill bacteria in biofilms, and when stopped, culminates in growing and spreading of the bacteria from biofilms 7 . Biofilm formation also mediates the spreading of the antibiotic resistance traits in nosocomial pathogens by developing mutation rates and the exchange of genes responsible for antibiotic resistance 8 . Biofilms are closely involved in higher antibiotic resistance because of several conditions including lower penetration of antibiotics, lower growth rate of bacteria in biofilms and altered metabolic requirements. Eventually, the surviving isolates in the inner portion of biofilms are likely to possess a higher probability of acquiring the ability to develop biofilms as well as multidrug resistance in clinical settings 9 . Biofilm forming strains are more frequently isolated from non-fluid tissues, in particular bone and soft tissues, and also MDR pathogens are more often biofilm formers. Several studies have shown that methicillin-resistance can alter the ability of the S. aureus isolates regarding biofilm production 10 . Previous studies on the biofilm formation among MDR isolates and the relationship to clinical manifestations are scarce 11 . The aim of this study was to detect the biofilm production and the biofilm encoding genes in MDR S. aureus isolates.
Methodology
This cross sectional study was conducted at a hospital in Tehran, Iran from July 2012 to January 2013. Patients admitted with the infections of the different sites of the body were selected as study population. The S. aureus isolates were selected from a hospital. MDR SA isolates were collected from different clinical sites of the patients and the specimens were blood, tracheal aspirate, wound swab, sputum and other. The isolates were collected from intensive care unit (ICU), infectious diseases, in-patient and pediatrics settings. In addition, the isolates were identified with catalase, coagulases, acid production from mannitol on mannitol salt agar and DNase tests. The DNA was amplified with specific primers to detect the mecA gene, SCCmec types, agr specific groups and biofilm related genes, including the icaADBC, clfAB, fnbAB, cna, ebps, eno, fib and bbp genes among the clinical isolates. The annealing temperature was 55ᵒC (30s) for mecA gene and 51ᵒC (1min) for SCCmec types, according to Zhang study 13 . For observation of the PCR products by electrophoresis, 5µl of each product was mixed with 1µl of each gel red and loading buffer dyes, and were run in 1% agarose gel electrophoresis and was observed by transluminator uv. The relationship between multidrug resistance and biofilm formation was evaluated by the Pearson ChiSquare test where any difference less than 0.05 was considered significant.
Results
The bacterial isolates were collected from different hospital settings and clinical sites, according to tubular forms 1 and 2. Among the total of 209 S. aureus isolates, 30.6% (n= 64) were methicillinresistant with oxacillin disk and in addition by detection of mecA gene with 147bp size. Of 64 MRSA, 56% (n= 36) were resistant to all the used antibiotics (MDR MRSA) including amoxicillin, tetracycline, erythromycin, clindamycin, trimethoprim-sulfamethoxazole (except for 6 isolates), gentamicin and ciprofloxacin. Also, 24 isolates in this study were multidrug-resistant and methicillin susceptible S.aureus (MDR-MSSA). All these isolates were resistant to amoxicillin, erythromycin and tetracycline, and the majority was resistant to ciprofloxacin (79%) and clindamycin (62.5%). The majority of MDR isolates were belonged to ICU setting. The resistance to trimethoprim-sulfamethoxazole and gentamicin between MDR-MRSA and MDR-MSSA were significant (table2). All the MDR-MRSA and the majority of MDR-MSSA isolates were strong biofilm producers in the Mtp assay.
Figure 1: The hospital settings from which the bacterial isolates were collected
All the MDR-MRSA carried SCCmec type III with a 280 bp size PCR product. The rate of antibiotic resistance among these isolates was significantly higher than MSSA (Pv = 0.012). Six isolates were susceptible to co-trimoxazole (SXT). In the current study, isolates with SCCmec type III were resistant to more variety of antibiotics compared to other SCC types. The majority of MDR-MRSA was belonged to agrI (67%, n= 24), followed by agr II (17%, n= 6), agrIV (11%, n= 4) and agrIII (5.5%, n= 2). There was not a confirmed relationship between the agr groups and antibiotic susceptibility pattern or biofilm production by the isolates.
Figure 2: Different clinical sites the bacterial isolates
The frequency of icaADBC genes in MDR-MRSA were 75% (n= 27), 61% (n=22), 72% (n= 26) and 72% (n= 26), respectively. Furthermore, the prevalence of clfA, clfB, fnbA, fnbB, fib, can, eno, ebps and bbp genes was 100%, 100%, 67%, 56%, 80%, 78%, 7% and 0%, respectively (table 2) . No relation between each of the agr specific groups and biofilm encoding genes among these isolates was confirmed as exhibited in table 3. The high prevalence of these associated genes was correlated with strong biofilm production in the isolates. The differences among MSSA, MRSA and MDR isolates regarding biofilm formation and the presence of biofilm related genes has been depicted in tubular form 3. 
Discussion
In the present study, the prevalence of MRSA was 30.6%. In previous studies it was not high [14] [15] [16] . However several other published surveys from Iran have determined that MRSA frequency is relatively high [14] [15] . Systemic review by Askari 14 exhibited that that MRSA prevalence is more than 50.0% in Iran. The difference in these results originates mainly from differences in the genetic background of strains, clinical origins and epidemiological areas of studies. In this present study, the MRSA isolates exhibited significantly more resistance to the used antibiotics, except to vancomycin and linezolid. Among the 64 MRSA 36(56%) isolates were resistant to the all the antibiotics contained SCCmec type III. Although 6 isolates with SCCmec type III were only susceptible to SXT, vancomycin and linezolid. Moreover, 24 MSSA isolates were MDR S. aureus. All these isolates were resistant to amoxicillin, tetracycline and erythromycin. The majority of MDR isolates were from ICU patients indicating that the isolates may be related to each other. In the phenotypic biofilm production, the MDR isolates produced biofilms strongly; which indicates that biofilm production can highly affect the extent of antibiotic resistance among multidrug-resistant isolates. Several previous studies have demonstrated this relationship 9, 16 . In fact the SCCmec type III contains a variety of genetic elements that confer resistance to several antibiotics and other compounds. According to previous results the majority of healthcare associated MRSA harbor the SCCmec type III 15, 17 . Also these MRSA were significantly more resistant to antibiotics enhancing the idea that these isolates had caused hospital acquired infections. In this study, all the MRSA with other SCCmec types (I, V) showed resistance to a lower number of the antibiotics. This study depicts the importance of SCCmec type III in the multidrug antibiotic resistance of MRSA. The majority (73.2%, n= 26) of multidrug MRSA was belonged to agrI (67%, n= 24) followed by agrII (19.5%, n= 7), agrIV (8%, n= 3) and agrIII (5.5%, n= 2). In previous studies agrI was the predominant specific group 16 . The agr groups play an important role in the regulation of several virulence factors of S. aureus. However, the relationships between each specific group and pathogenesis, clinical manifestations and drug resistance of MRSA isolates have not been certainly determined.
In this study, all the MDR-MRSA strains were capable of producing biofilm strongly by attachment into wells of micro-titre tissue plates. This result emphasizes the role of biofilm formation in various persistent and chronic infections caused by MDR-MRSA that do not response to antimicrobial therapy. Furthermore, the majority (72%) of multidrug MRSA harbored icaAD genes necessary for biofilm formation. As mentioned, these gene form biofilm via a synthesis of a Polysaccharide Inter-cellular Adhesion (PIA). The frequency of icaADBC genes were 75% (n= 27), 61% (n=22), 72% (n= 26) and 72% (n= 26) respectively. The high prevalence of the ica genes along with strong biofilm formation justifies the resistance of MRSA isolates to a myriad of adverse conditions in addition to antibiotics. Furthermore, in the previous study, all these isolates can express the biofilm related genes in Real time PCR assay. PIA related biofilms are mainly acquired from medical devices and catheters and culminate in systemic infections, and also make the treatment very more difficult [14] [15] . In this study several patients had died albeit antibiotic therapy. Previous studies have also determined the high prevalence and importance of these genes in biofilm producing isolates. Semczuk et al 18 have mentioned that all the isolates producing biofilm phenotypically harbored icaAD genes. In Hou's study 14 , among 55.56% of isolates that produced biofilm in phenotypic test, 11.11% contained the icaA gene; however, the other genes have not been investigated. In this study, methicillin resistant isolates harbored higher rate of icaADBC genes compared to MSSA; no significant difference was confirmed, similar to two other studies [15] [16] . Moreover, Smith 17 determined no significant relation between susceptibility to methicillin and biofilm formation.
Likewise, Rasha 19 detected the icaAD genes in 32% of blood and catheter isolates. In Zmantar's study 20 , 36 of 46 Staphylococcal isolates harbored icaA and icaD genes; while Grinholc and coworkers 21 did not detect icaD but all strains were icaA positive 14 .
Meriem detected the icaAD genes in 17(38.5%) of the 44 Staphylococcal isolates from urinary tract. In the Wang study 20 , biofilm formation in most of the isolates was PIA dependent. On the other hand, clinical origin of the isolates and infection site may be an important factor in the ability of the isolates to biofilm formation. Smith 17 depicted that isolates of S. aureus from infected skin lesions were significantly more capable of producing biofilms than those isolated from blood and other infected sites. Elena 21 suggests that the ica genes might be more prevalent in Staphylococcus strains isolated from the hospitalized patients or the staff, than healthy individuals or from the community. The previous studies about biofilm production in MDR-MRSA isolates are scarce. However, there is a relationship between these isolates and biofilm formation. Furthermore, in this study the prevalence of clfA, clfB, fnbA, fnbB, fib, eno, can, ebps and bbp genes was 100%, 100%, 67%, 56%, 80%, 78%, 65%, 7% and 0%, respectively. Similarly, in Atshan's study 22 , all MRSA and MSSA strains harbored clfA,B genes. Investigation showed that 69.7% of the isolates harbored clfAB genes 22 . However, Momtaz 23 confirmed that nearly 20% of S. aureus isolates causing mastitis contained clfA gene. It seems that the kind of clinical isolates according to site of infections may be important in the prevalence of these genes essential for colonization in addition to the epidemiological differences. Furthermore, all the MRSA and MSSA isolates harbored clfAB genes. In this study the prevalence of fnbA and fnbB was 60% and 47%, respectively. A study by Wastfelt 24 has detected the fib gene in all S. aureus strains. Similarly, in previous study 20 all isolates that conferred clindamycin inducible resistance and also vancomycin intermediate S. aureus (VISA) isolates carried this gene. However, in phenotypic test VISA isolates produced lower amount of biofilms. The prevalence of eno and cna genes was 78% and 63%, respectively, showing the important role of these genes in colonization of S. aureus. Because of the high presence of laminin and collagen in tissues, S. aureus isolates can easily and rapidly bind to the specific receptors. The limitation of this study was low number of MDR isolates; thus more studies are needed in future to detect biofilm formation in MDR nosocomial isolates.
Conclusion
All the MRSA with multiple antibiotic resistances contained SCCmec type III and belonged to agrI. The frequency of different biofilm associated genes and likewise the amount of biofilm production was high in MDR-MRSA isolates. MDR isolates of S.aureus might be capable of strong biofilm formation that contributes to the higher antibiotic resistance.
